Literature DB >> 12718902

Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model.

Kai Wang1, Paul D Kessler, Zhongmin Zhou, Marc S Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Melina Kibbe, Imre Kovesdi, Douglas E Brough, Eric J Topol, A Michael Lincoff.   

Abstract

In this study the effect of local adenoviral-mediated delivery of inducible nitric oxide synthase on restenosis was evaluated in a porcine coronary stented model. Local gene transfer of recombinant adenoviral vectors that encode human inducible nitric oxide synthase (AdiNOS) was tested. Control vector (AdNull) lacked a recombinant transgene. Endoluminal delivery of 1.0 x 10(11) adenoviral particles was accomplished in 45 s using the Infiltrator catheter (Interventional Technologies, San Diego, CA). Coronary stents were deployed, oversized by a ratio of 1.2:1, in the treated segments immediately after gene transfer. Fourteen animals were sacrificed at day 28 to evaluate the effects of iNOS gene transfer on morphometric indices, and 4 animals were sacrificed at day 4 for detection of human iNOS expression by RT-PCR. iNOS mRNA was detected in six of eight iNOS-transferred arteries, whereas no expression of human iNOS was detected in the nontarget arteries. Morphometric analysis showed that iNOS transfer significantly reduced neointimal formation (3.41 +/- 1.12 mm(2) vs 2.14 +/- 0.68 mm(2), P < 0.05). We concluded that efficient intramural adenovirus-mediated iNOS transfer can be achieved by using Infiltrator catheters. iNOS gene transfer significantly reduces neointimal hyperplasia following stent injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718902     DOI: 10.1016/s1525-0016(03)00061-3

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  16 in total

1.  Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors.

Authors:  Sifeng Chen; Matthias Kapturczak; Scott A Loiler; Sergei Zolotukhin; Olena Y Glushakova; Kirsten M Madsen; Richard J Samulski; William W Hauswirth; Martha Campbell-Thompson; Kenneth I Berns; Terence R Flotte; Mark A Atkinson; C Craig Tisher; Anupam Agarwal
Journal:  Hum Gene Ther       Date:  2005-02       Impact factor: 5.695

2.  Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Authors:  Ilia Fishbein; Ivan S Alferiev; Origene Nyanguile; Richard Gaster; John M Vohs; Gordon S Wong; Howard Felderman; I-Wei Chen; Hoon Choi; Robert L Wilensky; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 3.  Percutaneous approaches for efficient cardiac gene delivery.

Authors:  Kiyotake Ishikawa; Jaume Aguero; Charbel Naim; Kenneth Fish; Roger J Hajjar
Journal:  J Cardiovasc Transl Res       Date:  2013-06-08       Impact factor: 4.132

Review 4.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

Review 5.  Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

6.  Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.

Authors:  Kathleen G Raman; Robin E Gandley; Jennifer Rohland; Mazen S Zenati; Edith Tzeng
Journal:  J Vasc Surg       Date:  2010-12-15       Impact factor: 4.268

Review 7.  Factors that affect mass transport from drug eluting stents into the artery wall.

Authors:  Barry M O'Connell; Tim M McGloughlin; Michael T Walsh
Journal:  Biomed Eng Online       Date:  2010-03-09       Impact factor: 2.819

8.  Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.

Authors:  Luis A Brito; Saradha Chandrasekhar; Steven R Little; Mansoor M Amiji
Journal:  Biomed Eng Online       Date:  2010-09-27       Impact factor: 2.819

9.  Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries.

Authors:  Ilia Fishbein; Ivan Alferiev; Marina Bakay; Stanley J Stachelek; Peter Sobolewski; Meizan Lai; Hoon Choi; I-W Chen; Robert J Levy
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

Review 10.  Cardiovascular gene therapy: current status and therapeutic potential.

Authors:  M M Gaffney; S O Hynes; F Barry; T O'Brien
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.